首页 | 本学科首页   官方微博 | 高级检索  
     

头颈部鳞癌相关生物标志物与免疫治疗预后的关系
引用本文:张璐,陆静钰(综述),陆海军(审校). 头颈部鳞癌相关生物标志物与免疫治疗预后的关系[J]. 实用肿瘤学杂志, 2021, 35(1): 55-58. DOI: 10.11904/j.issn.1002-3070.2021.01.011
作者姓名:张璐  陆静钰(综述)  陆海军(审校)
作者单位:1.山东省青岛大学(青岛 266071);2.滨州医学院;3.青岛大学附属医院
基金项目:国家卫生计生委医院管理研究所肿瘤靶向研究专项基金项目(编号:WJWYGS-201818)。
摘    要:头颈部鳞癌(HNSCC)是世界上第六大常见的恶性肿瘤,每年发病超过55万,死亡超过30万人,吸烟和饮酒是其主要危险因素.HNSCC的治疗方案主要是基于TNM分期、以外科手术为主的综合疗法(放疗、化疗及生物治疗).对于HNSCC的治疗,其5年生存率近年来一直没有改善,因此,需要新的治疗方法提高患者生存率,改善患者生活质量...

关 键 词:头颈部鳞癌  HPV  p16  EBV  预后  免疫治疗

The relationship between biomarkers of head and neck squamous cell carcinoma and prognosis of immunotherapy
ZHANG Lu,LU Jingyu,LU Haijun. The relationship between biomarkers of head and neck squamous cell carcinoma and prognosis of immunotherapy[J]. Journal of Practical Oncology, 2021, 35(1): 55-58. DOI: 10.11904/j.issn.1002-3070.2021.01.011
Authors:ZHANG Lu  LU Jingyu  LU Haijun
Affiliation:1.Qingdao University in Shandong Province,Qingdao 266071,China;2.Binzhou Medical University;3.The Affiliated Hospital of Qingdao University
Abstract:Head and neck squamous cell carcinoma(HNSCC)is the sixth most common malignant tumor in the world,with an annual incidence of more than 550,000 cases and 300,000 deaths.Smoking and drinking alcohol are the main risk factors.The treatment plan of HNSCC is mainly based on TNM staging and primary surgery with comprehensive therapy(radiotherapy,chemotherapy and biological therapy).For the treatment of HNSCC,the 5-year survival rate has not improved in recent years.Therefore,new treatment methods are needed to increase the survival rate and improve the quality of patient life.The current research hotspot is the widespread application of immunotherapy-based biological targeted therapy for HNSCC.This study aims to explore the relationship between biomarkers of HNSCC and prognosis of immunotherapy.
Keywords:Head and neck squamous cell carcinoma(HNSCC)  HPV  p16  EBV  Prognosis  Immunotherapy
本文献已被 维普 等数据库收录!
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号